#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Dent's disease Duchenne muscular dystrophy gene carrier Epilepsy Congenital pseudarthrosis Haemophilia B-cell lymphoma Myxoid liposarcoma Antisynthetase syndrome Anal fistula Bronchiectasis B-cell lymphoma refractory Burkitt's lymphoma Haemolytic uraemic syndrome Angiosarcoma non-metastatic Glycogen storage disease type II More trials…

    Learn about Rare Diseases

    Myelodysplastic syndrome – Life with Disease Wolfram syndrome – Basic Information Small intestine leiomyosarcoma – Diagnostics Prader-Willi syndrome – Trials in Disease Amyotrophic lateral sclerosis – Diagnostics Gastrointestinal stromal tumour Brain stem glioma – Trials in Disease Breast angiosarcoma metastatic Hyperoxaluria – Trials in Disease Andersen-Tawil syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    L-Lysine Hydrochloride Noradrenaline Tartrate Tecovirimat Divarasib F1245/05 Levofloxacin Mycophenolic Acid Io102 Hydrochloride Propranolol Hydrochloride Indometacin IMEROPRUBART Dimeticone Lonapegsomatropin Alpha-Tocopherol Ly3537982 THEOPHYLLINE ANHYDROUS Ads-011 Linerixibat NORETHISTERONE ACETATE Ixazomib More therapies…

    Learn about Your Condition

    Influenza Cardiac failure acute Multiple sclerosis Hypochondroplasia Retinitis pigmentosa Hypoxia Thrombosis prophylaxis Juvenile absence epilepsy Emphysema Thyroid disorder Metastatic glioma Malformation venous Cardiac failure congestive Ocular hypertension Sepsis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. IRCCS Humanitas Research Hospital

IRCCS Humanitas Research Hospital

Via Alessandro Manzoni 56, Rozzano, 20089, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of Guselkumab for Patients with Fistulizing Perianal Crohn’s Disease

    Not recruiting

    3 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Guselkumab
    Belgium Czechia France Germany Greece Hungary +5

  • Study on the Effects and Safety of Efgartigimod PH20 SC for Adults with Active Idiopathic Inflammatory Myopathy

    Not recruiting

    4 1
    Investigated Diseases:
    • Idiopathic inflammatory myopathy
    Investigated Drugs:
    • Efgartigimod Alfa
    Austria Belgium Bulgaria Cyprus Czechia Denmark +13

  • Study on the Effects of FDY-5301 for Patients with Anterior ST-Elevation Myocardial Infarction (Heart Attack)

    Not recruiting

    3 1
    Investigated Drugs:
    • Sodium Iodide
    Czechia Germany Hungary Italy The Netherlands Poland +3

  • Study Comparing Divarasib, Sotorasib, and Adagrasib for Patients with Advanced or Metastatic KRAS G12C-Positive Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Austria Belgium Denmark Finland France Germany +7

  • Study Comparing AVT16 and Vedolizumab for Adults with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute haemorrhagic ulcerative colitis
    Investigated Drugs:
    • Vedolizumab
    • Sodium Chloride
    Bulgaria Croatia Czechia Greece Hungary Italy +5

  • Study of Itolizumab with Corticosteroids for Initial Treatment of Acute Graft Versus Host Disease in Patients After Bone Marrow Transplant

    Not recruiting

    3 1
    Investigated Diseases:
    • Graft versus host disease
    • Allogenic stem cell transplantation
    Investigated Drugs:
    • Itolizumab
    Belgium France Germany Italy Portugal Spain

  • Study of Inhaled Pirfenidone for Patients with Progressive Pulmonary Fibrosis

    Not recruiting

    2 1
    Investigated Diseases:
    • Pulmonary fibrosis
    Investigated Drugs:
    • Pirfenidone
    Belgium France Germany Italy The Netherlands Poland +1

  • Study on the Long-Term Safety and Effectiveness of Ozanimod for Adults with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Ozanimod
    Belgium Bulgaria Czechia Hungary Italy Poland +1

  • Study on Remibrutinib for Adults with Chronic Inducible Urticaria Uncontrolled by H1-Antihistamines

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Urticaria cholinergic
    • Cold urticaria
    • Urticaria chronic
    Investigated Drugs:
    • Remibrutinib
    France Germany Hungary Italy The Netherlands Poland +4

  • Study of petosemtamab compared to standard therapy in previously treated patients with metastatic or recurrent head and neck cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Cetuximab
    • Docetaxel
    • Methotrexate
    Belgium Czechia France Germany Greece Hungary +6
Previous Page
1 … 42 43 44 45 46 … 69
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!